Dara Keian Dayani is a longtime pharmaceutical leader who serves as senior director, US marketing, at Vera Therapeutics, Inc. She’s responsible for developing and executing a multi-year US brand strategy for the novel drug atacicept in IgA Nephropathy (IgAN). Among her accomplishments has been guiding brand messaging and product positioning, as well as channel optimization and pricing strategy. Dara Keian Dayani also informs regulatory strategy and clinical development and has delivered thought-leader engagement and disease education to boost product awareness.
From 2024 to 2025, Ms. Dayani served as Pfizer Oncology’s director of US breast cancer portfolio marketing. The integrated marketing plan she developed effectively communicated the portfolio promise while delivering a unified visual and strategic framework across brands. Her cross-brand approach spanned digital campaigns, sales materials, and conference content.
Ms. Dayani holds an MBA from the University of Washington with an emphasis in strategy and marketing. She completed her BS in pharmaceutical sciences at the Bouve College of Health Sciences and earned her doctor of pharmacy at Northeastern University in Boston. Her favorite free-time activities include exercise, cooking, and reading.